COL Group Co.,Ltd. (SHE:300364)

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	19,538	17,905	18,781	7,299	10,786	5,607
Market Cap Growth	-13.99%	-4.66%	157.33%	-32.33%	92.35%	87.59%
Enterprise Value	19,683	18,057	18,755	6,761	10,197	4,937
Last Close Price	26.82	24.53	25.73	9.92	14.83	7.71
PE Ratio	-	-	210.00	-	109.18	114.62
Forward PE	-	6.94	6.94	6.94	6.94	6.94
PS Ratio	16.71	15.45	13.33	6.19	9.07	5.75
PB Ratio	21.24	17.80	14.84	6.02	6.67	3.84
P/TBV Ratio	42.13	32.78	23.65	8.44	8.27	4.62
P/FCF Ratio	-	-	-	-	-	37.93
P/OCF Ratio	-	-	-	567.87	345.95	28.19
EV/Sales Ratio	16.83	15.58	13.31	5.73	8.58	5.06
EV/EBITDA Ratio	-	-	279.51	-	51.37	41.53
EV/EBIT Ratio	-	-	-	-	78.20	-
EV/FCF Ratio	-133.55	-	-	-	-	33.40
Debt / Equity Ratio	0.37	0.33	0.21	0.23	0.16	0.09
Debt / EBITDA Ratio	-	-	3.51	-	1.25	1.07
Debt / FCF Ratio	-	-	-	-	-	0.86
Asset Turnover	0.70	0.67	0.76	0.58	0.57	0.52
Inventory Turnover	11.79	14.36	40.38	386.94	95.72	39.80
Quick Ratio	0.71	0.88	1.00	1.26	1.96	2.20
Current Ratio	1.30	1.29	1.41	1.72	2.42	2.58
Return on Equity (ROE)	-24.87%	-21.36%	7.26%	-25.35%	9.40%	4.04%
Return on Assets (ROA)	-10.14%	-9.20%	-0.37%	-6.38%	3.90%	-0.92%
Return on Capital (ROIC)	-12.42%	-11.14%	-0.45%	-7.68%	4.70%	-1.15%
Return on Capital Employed (ROCE)	-	-	-	-	7.90%	-
Earnings Yield	-1.34%	-1.36%	0.48%	-4.96%	0.92%	0.87%
FCF Yield	-0.75%	-0.83%	-0.67%	-1.82%	-0.55%	2.64%
Payout Ratio	-	-	10.35%	-	5.85%	4.47%
Buyback Yield / Dilution	6.98%	7.00%	-7.20%	2.44%	-1.04%	3.36%
Total Shareholder Return	-	7.00%	-7.20%	2.44%	-1.04%	3.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.